Clinical Trials List
Protocol NumberCQGE031E12301
2021-10-30 - 2022-10-18
Phase III
Recruiting2
ICD-10L50.6
Contact urticaria
ICD-10L50.8
Other urticaria
ICD-9708.8
Other specified urticaria
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- WEI-HSIN WU 無
- Chih-Chieh Chan 無
- 卓雍哲 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Yao Hsu 無
- Chun-Wei Lu 無
- 陳偉迪 無
- 陳偉迪 未分科
- Chin-Yi Yang 無
- 紀景琪 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9-12 participants
-
Global
428 participants
